Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 11, 2025 · Filed Apr 23, 2025
An Aim Immunotech director paid $50K out of pocket for Aim Immunotech shares. 3 other people at Aim Immunotech bought some too, in the same month. Shares held went up 196850% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$50,000
Shares × reported transaction price
$25K–$100K
+196850.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Apr 11, 2025 · filed 12 days later
The CEO of Aim Immunotech paid $50K out of pocket for Aim Immunotech shares. 3 other people at Aim Immunotech bought some too, in the same month. Shares held went up 104% with this purchase.
Insider buying
Traded Apr 11, 2025 · filed 12 days later
An Aim Immunotech director paid $5K out of pocket for Aim Immunotech shares. 3 other people at Aim Immunotech bought some too, in the same month. Shares held went up 61% with this purchase.
Insider buying
Traded Apr 4, 2025 · filed 3 days later
The CEO of Aim Immunotech paid $2.6K out of pocket for Aim Immunotech shares. 3 other people at Aim Immunotech bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
